SOLCO HEALTHCARE U.S. - Trademark Details
Status: 710 - Cancelled - Section 8
Image for trademark with serial number 85619481
Serial Number
85619481
Registration Number
4478651
Word Mark
SOLCO HEALTHCARE U.S.
Status
710 - Cancelled - Section 8
Status Date
2020-09-11
Filing Date
2012-05-08
Registration Number
4478651
Registration Date
2014-02-04
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2013-03-05
Attorney Name
Law Office Assigned Location Code
L40
Employee Name
RIRIE, VERNA BETH
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"HEALTHCARE U.S."
Goods and Services
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating hypertension
Goods and Services
Analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; antimicrobial preservatives for cosmetics and pharmaceuticals; pharmaceutical astringents; balms for pharmaceutical purposes; cream of tartar for pharmaceutical purposes; creosote for pharmaceutical purposes; dermatological pharmaceutical products; digestives for pharmaceutical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; ferments for pharmaceutical purposes; inhaled pharmaceutical preparations for the treatment of respiratory disease; injectable pharmaceuticals for treatment of anaphylactic reactions; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; iodine for pharmaceutical purposes; liquorice for pharmaceutical purposes; menthol for pharmaceutical purposes; pharmaceutical antitussive-cold preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, injectable contraceptives; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating hypertension; pharmaceutical products for treating respiratory disease and asthma; pharmaceutical products for the treatment of joint disease; plant extracts for medical, veterinary and pharmaceutical purposes; potassium preparations for pharmaceutical purposes; pharmaceutical preparations and substances for weight loss; vitamin and mineral supplements for use as ingredients in the food and pharmaceutical industry; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of coatings for facilitating the delivery of a wide range of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; biological preparations for the treatment of cancer and autoimmune deficiencies and disorders; pharmaceutical, veterinary and sanitary preparations, namely, conjugates of organic and inorganic chemicals with polypeptides, proteins, artificial polypeptides, artificial proteins produced by genetic engineering and for the treatment of viral and infectious diseases, immune system disorders, cancer, diabetes, cardiovascular diseases, central nervous system disorders and diseases; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for treating skin disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer
Goods and Services
Drug delivery system; medical apparatus and units for dosage, measuring and monitory, namely, drug delivery devices and systems
Goods and Services
Bottles for pharmaceuticals sold empty
Goods and Services
Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
Goods and Services
Pharmaceutical drug development services; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Drug discovery services
Goods and Services
Medical and pharmaceutical consultation
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2020-09-11
Primary Code
005
First Use Anywhere Date
2009-06-03
First Use In Commerce Date
2009-06-03
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2020-09-11
Primary Code
035
First Use Anywhere Date
2010-12-31
First Use In Commerce Date
2010-12-31
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2020-09-11
Primary Code
044
First Use Anywhere Date
2010-12-31
First Use In Commerce Date
2010-12-31
Correspondences
Name
MAUREEN C. KASSNER
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2012-05-11NEW APPLICATION ENTERED IN TRAM
2012-05-15NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2012-08-29ASSIGNED TO EXAMINER
2012-09-05NON-FINAL ACTION WRITTEN
2012-09-05NON-FINAL ACTION E-MAILED
2012-09-05NOTIFICATION OF NON-FINAL ACTION E-MAILED
2012-12-19TEAS RESPONSE TO OFFICE ACTION RECEIVED
2012-12-27ASSIGNED TO LIE
2013-01-05CORRESPONDENCE RECEIVED IN LAW OFFICE
2013-01-05TEAS/EMAIL CORRESPONDENCE ENTERED
2013-01-24EXAMINERS AMENDMENT -WRITTEN
2013-01-24EXAMINERS AMENDMENT E-MAILED
2013-01-24NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2013-01-24EXAMINER'S AMENDMENT ENTERED
2013-01-25APPROVED FOR PUB - PRINCIPAL REGISTER
2013-01-29LAW OFFICE PUBLICATION REVIEW COMPLETED
2013-02-13NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2013-03-05PUBLISHED FOR OPPOSITION
2013-03-05OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2013-04-30NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2013-08-05TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
2013-08-26CASE ASSIGNED TO INTENT TO USE PARALEGAL
2013-08-28APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2013-10-30TEAS STATEMENT OF USE RECEIVED
2013-10-30USE AMENDMENT FILED
2013-11-10STATEMENT OF USE PROCESSING COMPLETE
2013-11-21SU - NON-FINAL ACTION - WRITTEN
2013-11-21NON-FINAL ACTION E-MAILED
2013-11-21NOTIFICATION OF NON-FINAL ACTION E-MAILED
2013-12-19SU-EXAMINER'S AMENDMENT WRITTEN
2013-12-19EXAMINERS AMENDMENT E-MAILED
2013-12-19NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2013-12-23EXAMINER'S AMENDMENT ENTERED
2013-12-23ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2013-12-27ASSIGNED TO LIE
2013-12-28LAW OFFICE REGISTRATION REVIEW COMPLETED
2013-12-31NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2014-02-04REGISTERED-PRINCIPAL REGISTER
2019-02-04COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2020-09-11CANCELLED SEC. 8 (6-YR)